4-Amino-3-Chlorophenol CAS 17609-80-2 Lenvatinib Mesylate Intermediate Purity > 99.0% (HPLC)

Lus piav qhia luv luv:

Lub npe tshuaj: 4-Amino-3-Chlorophenol

CAS: 17609-80-2 Nr

Purity:> 99.0% (HPLC)

Cov tsos mob: Brown Solid Powder

Intermediate ntawm Lenvatinib Mesylate CAS 857890-39-2

Hu rau: Dr. Alvin Huang

Txawb/Wechat/WhatsApp: +86-15026746401

E-Mail: alvin@ruifuchem.com


Product Detail

Yam khoom

Khoom cim npe

Nqe lus piav qhia:

Chemical Properties:

Tshuaj npe 4-Amino-3-Chlorophenol
Synonyms 3-Chloro-4-Aminophenol;Lenvaint-G
CAS Nr 17609-80-2
CAT Number RF-PI 1968
Tshuag xwm txheej Nyob rau hauv Tshuag, ntau lawm Scale mus txog Tons
Molecular Formula C6H6ClNO
Molecular Luj 143.57 Nws
Qhov ntom 1.406 ± 0.060g / cm3
Hom Ruifu Tshuaj

Specifications:

Yam khoom Specifications
Qhov tshwm sim Brown Solid Powder
1 H NMR Spectrum Raws li tus qauv
Identification-HPLC Lub sijhawm khaws cia zoo ib yam li tus qauv
Purity / Analysis Method > 99.0% (HPLC)
Melting Point 138.0 ~ 141.0 ℃
Poob rau ziab <1.00%
Residue ntawm Ignition <0.30%
Tag nrho cov impurities <1.00%
Test Standard Enterprise Standard
Kev siv Intermediate ntawm Lenvatinib Mesylate (CAS: 857890-39-2)

Pob & Cia:

Pob: Lub raj mis, Aluminium ntawv ci hnab, 25kg / Cardboard Nruas, los yog raws li tus neeg yuav tsum tau muaj

Cia txias:Khaws rau hauv cov thawv ntim khoom ntawm qhov chaw txias thiab qhuav;Tiv thaiv los ntawm lub teeb thiab noo noo

Qhov zoo:

1

FAQ:

Daim ntawv thov:

4-Amino-3-Chlorophenol (CAS: 17609-80-2) yog ib qho tseem ceeb kws tshuaj nruab nrab, uas yog dav siv nyob rau hauv kev tsim thiab synthesis ntawm anti-tumor, kab mob plawv, neurological kab mob tshuaj.4-Amino-3-Chlorophenol yog ib qho tseem ceeb nruab nrab ntawm kev npaj ntawm Lenvatinib Mesylate (CAS: 857890-39-2).Tsim los ntawm Eisai Inc., lenvatinib mesylate yog vascular endothelial growth factor receptor (VEGF) inhibitor uas muaj kev ua haujlwm tiv thaiv VEGF subtypes 1, 2, thiab 3 thiab tau pom zoo los ntawm FDA hauv 2015 rau kev kho mob qog noj ntshav sib txawv hauv zos. rov tshwm sim, metastatic, lossis kev loj hlob thiab tsis teb rau kev kho mob radioactive iodine.Nyob rau lub Tsib Hlis 2016, FDA tau pom zoo cov tshuaj raws li kev kho mob ua ke nrog everolimus rau kev kho mob ntawm lub raum cell carcinoma.Vim tias VEGF (thiab fibroblast kev loj hlob zoo tshaj plaws receptors, hu ua FGFRs) tau xav tias ua lub luag haujlwm hauv cov hlab plawv cov hlab ntsha, VEGF2R thiab FGFR inhibition tau xav tias yog cov txheej txheem tom qab thawj cov kev mob tshwm sim ntawm lenvatinib mesylate, uas yog kub siab.

Sau koj cov lus ntawm no thiab xa tuaj rau peb